MX2009012044A - Eliminacion de interferencia en inmunoensayos causada por anticuerpos anti-carbohidrato. - Google Patents
Eliminacion de interferencia en inmunoensayos causada por anticuerpos anti-carbohidrato.Info
- Publication number
- MX2009012044A MX2009012044A MX2009012044A MX2009012044A MX2009012044A MX 2009012044 A MX2009012044 A MX 2009012044A MX 2009012044 A MX2009012044 A MX 2009012044A MX 2009012044 A MX2009012044 A MX 2009012044A MX 2009012044 A MX2009012044 A MX 2009012044A
- Authority
- MX
- Mexico
- Prior art keywords
- drug
- immunoassays
- elimination
- interference
- caused
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a ensayos para la detección de un anticuerpo anti-fármaco en general, y en particular, a la detección de un anticuerpo anti-fármaco, en donde el fármaco tiene una porción de carbohidrato. La invención también se dirige a ensayos para la detección de un fármaco en general y en particular, a la detección de un fármaco en donde el fármaco tiene una porción de carbohidrato. La invención además se dirige a métodos para identificar sujetos apropiados para tratamiento con un fármaco que contiene una porción de carbohidrato.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92814407P | 2007-05-07 | 2007-05-07 | |
| US92843807P | 2007-05-08 | 2007-05-08 | |
| PCT/US2008/062739 WO2008137885A1 (en) | 2007-05-07 | 2008-05-06 | Elimination of interference in immunoassays caused by anti-carbohydrate antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009012044A true MX2009012044A (es) | 2009-11-18 |
Family
ID=39666131
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009012048A MX2009012048A (es) | 2007-05-07 | 2008-05-06 | Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato. |
| MX2009012044A MX2009012044A (es) | 2007-05-07 | 2008-05-06 | Eliminacion de interferencia en inmunoensayos causada por anticuerpos anti-carbohidrato. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009012048A MX2009012048A (es) | 2007-05-07 | 2008-05-06 | Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2142925A1 (es) |
| JP (1) | JP2010527005A (es) |
| KR (1) | KR20100029083A (es) |
| CN (1) | CN101680880A (es) |
| AU (1) | AU2008247352A1 (es) |
| BR (1) | BRPI0811290A2 (es) |
| CA (1) | CA2686206A1 (es) |
| IL (1) | IL201907A0 (es) |
| MX (2) | MX2009012048A (es) |
| RU (1) | RU2009141159A (es) |
| WO (1) | WO2008137885A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS54249B1 (en) | 2010-04-29 | 2016-02-29 | Theradiag Sa | PROCEDURE FOR DETECTION OF ANTI-MEDICINAL ANTIBODIES |
| EP3105592B1 (en) | 2014-02-11 | 2018-10-17 | Genzyme Corporation | Assays for detecting the presence or amount of an anti-drug antibody |
| EP3176580A1 (en) | 2015-12-01 | 2017-06-07 | Roche Diagnostics GmbH | Method for reduction of interferences in immunoassays |
| GB201522839D0 (en) * | 2015-12-23 | 2016-02-03 | Randox Lab Ltd And Randox Teoranta | Method |
| EP3475699B1 (en) * | 2016-06-23 | 2022-07-06 | Ablynx N.V. | Improved pharmacokinetic assays for immunoglobulin single variable domains |
| CN108535490A (zh) * | 2017-03-06 | 2018-09-14 | 苏州和锐生物科技有限公司 | 生物制剂血药浓度检测方法及试剂 |
| CN113514632A (zh) * | 2021-04-20 | 2021-10-19 | 中国科学技术大学 | 基于纳米抗体的微悬臂梁免疫传感方法 |
| WO2023204378A1 (ko) * | 2022-04-19 | 2023-10-26 | 의료법인 성광의료재단 | 혈액 내 항-약물항체 농도 측정을 통한 생물학적 약물에 대한 치료 반응성 예측 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5705353A (en) * | 1995-06-07 | 1998-01-06 | Beckman Instruments, Inc. | Method of reducing interferences in assays |
| US5856106A (en) * | 1995-11-01 | 1999-01-05 | Biotransplant, Inc. | Determination of antibody production against administered therapeutic glycoproteins, especially monoclonal antibodies |
-
2008
- 2008-05-06 JP JP2010507595A patent/JP2010527005A/ja not_active Withdrawn
- 2008-05-06 RU RU2009141159/15A patent/RU2009141159A/ru not_active Application Discontinuation
- 2008-05-06 AU AU2008247352A patent/AU2008247352A1/en not_active Abandoned
- 2008-05-06 CA CA002686206A patent/CA2686206A1/en not_active Abandoned
- 2008-05-06 MX MX2009012048A patent/MX2009012048A/es unknown
- 2008-05-06 CN CN200880015303A patent/CN101680880A/zh active Pending
- 2008-05-06 BR BRPI0811290-8A2A patent/BRPI0811290A2/pt not_active Application Discontinuation
- 2008-05-06 KR KR1020097025396A patent/KR20100029083A/ko not_active Application Discontinuation
- 2008-05-06 MX MX2009012044A patent/MX2009012044A/es not_active Application Discontinuation
- 2008-05-06 WO PCT/US2008/062739 patent/WO2008137885A1/en active Application Filing
- 2008-05-06 EP EP08755078A patent/EP2142925A1/en not_active Withdrawn
-
2009
- 2009-11-03 IL IL201907A patent/IL201907A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009012048A (es) | 2010-02-24 |
| CA2686206A1 (en) | 2008-11-13 |
| RU2009141159A (ru) | 2011-06-20 |
| AU2008247352A1 (en) | 2008-11-13 |
| CN101680880A (zh) | 2010-03-24 |
| BRPI0811290A2 (pt) | 2014-10-21 |
| KR20100029083A (ko) | 2010-03-15 |
| EP2142925A1 (en) | 2010-01-13 |
| JP2010527005A (ja) | 2010-08-05 |
| WO2008137885A1 (en) | 2008-11-13 |
| IL201907A0 (en) | 2010-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009012048A (es) | Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato. | |
| MY157955A (en) | Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody | |
| MX362075B (es) | Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo. | |
| MX2015016389A (es) | Inmumoensayo con interferencia suprimida para la deteccion de anticuerpos anti-farmacos en muestras de suero. | |
| MX2012004833A (es) | Analisis para detectar anticuerpos especificos a anticuerpos anti-ige terapeuticos y su uso en anafilaxis. | |
| ZA201000093B (en) | Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies | |
| SG170728A1 (en) | Anti-tumor cell antigen antibody therapeutics | |
| HK1097320A1 (en) | Detection of methamphetamine group drugs | |
| WO2006086208A3 (en) | 5-fluoro-uracil immunoassay | |
| MX2010013692A (es) | Deteccion de uso de cannabis. | |
| GB2449043A (en) | Water soluble conjugates for electrochemical detection | |
| RS54249B1 (en) | PROCEDURE FOR DETECTION OF ANTI-MEDICINAL ANTIBODIES | |
| WO2009055382A8 (en) | One-step immunoassays exhibiting increased sensitivity and specificity | |
| HK1126274A1 (en) | T cell assays t | |
| SG164389A1 (en) | Detection of a therapeutic antibody in an experimental animal | |
| EA200700345A1 (ru) | Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело | |
| ATE481642T1 (de) | Sondenkomplex | |
| MY149500A (en) | The quantitative determination of risedronate in urine by spe-lc-ms-ms | |
| BRPI0919987A8 (pt) | Dispositivo biosensor magnético e método para aplicar um campo magnético em uma superfície do sensor de um dispositivo biosensor magnético | |
| WO2006060188A3 (en) | Anti-tenascin monoclonal antibody immunoassays and diagnostic kits | |
| WO2010053772A3 (en) | Disease-associated antigens and methods of use thereof | |
| SI1991875T1 (sl) | Postopek za dokazovanje patoloških prionov | |
| ATE526582T1 (de) | Generisches verfahren für latex- agglutinationstests | |
| WO2007084570A3 (en) | High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis | |
| UA67778U (ru) | Способ количественного определения общего igm человека |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |